awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38809512-23E66A2C-A33A-41D3-8C5B-B55FE97CCBD3
Q38809512-23E66A2C-A33A-41D3-8C5B-B55FE97CCBD3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38809512-23E66A2C-A33A-41D3-8C5B-B55FE97CCBD3
Treatment of allergic children - Where is the progress (for the practicing allergist)?
P2860
Q38809512-23E66A2C-A33A-41D3-8C5B-B55FE97CCBD3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38809512-23E66A2C-A33A-41D3-8C5B-B55FE97CCBD3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
048eeee86544fa7b9af8a3631ee92806a0e7624c
P2860
A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.